Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech News Today.
Press releases published on May 7, 2025
GENFIT : Assemblée Générale Mixte du 17 juin 2025 — modalités de mise à disposition des documents préparatoires
GlobeNewswire
·
May 7, 2025
Lille (France), Cambridge (Massachusetts, États-Unis), Zurich (Suisse), le 7 mai 2025 – GENFIT (Nasdaq et Euronext : GNFT), société biopharmaceutique engagée dans l’amélioration de la vie des patients atteints de maladies rares du foie pouvant engager le …
Earlyworks Co., Ltd. Announces Receipt of Nasdaq Delisting Determination and Plan to Request a Hearing before the Nasdaq Hearings Panel
GlobeNewswire
·
May 7, 2025
TOKYO, May 07, 2025 (GLOBE NEWSWIRE) -- Earlyworks Co., Ltd. (Nasdaq: ELWS) (the “Company” or “Earlyworks”), a Japanese company operating its proprietary private blockchain technology, Grid Ledger System (“GLS”), today announced that it received a staff …
Veeco Announces Over $35 Million in Advanced Packaging Lithography System Orders From IDM & OSAT Customers
GlobeNewswire
·
May 7, 2025
PLAINVIEW, N.Y., May 07, 2025 (GLOBE NEWSWIRE) -- Veeco Instruments Inc. (NASDAQ: VECO) today announced its received over $35 million of orders for its AP300™ Lithography systems in recent quarters from a wide-range of IDM and OSAT customers. The orders …
WANG & LEE GROUP, Inc. Bid Price Deficiency
GlobeNewswire
·
May 7, 2025
HONG KONG, May 07, 2025 (GLOBE NEWSWIRE) -- WANG …
Oncocyte to Release First Quarter 2025 Results on May 12, 2025
GlobeNewswire
·
May 7, 2025
IRVINE, Calif., May 07, 2025 (GLOBE NEWSWIRE) -- Oncocyte Corp., (Nasdaq: OCX), a leading diagnostics technology company, today announced that it will report first quarter 2025 financial results after the market closes on Monday, May 12, 2025. Oncocyte …
Context Therapeutics Reports First Quarter 2025 Operating and Financial Results
GlobeNewswire
·
May 7, 2025
CTIM-76 and CT-95 in Phase 1 Clinical Trials Cash and cash equivalents of $89.4 million as of March 31, 2025 Company expects its cash and cash equivalents will continue to fund operations into 2027 PHILADELPHIA, May 07, 2025 (GLOBE NEWSWIRE) -- Context …
Fortinet Reports First Quarter 2025 Financial Results
GlobeNewswire
·
May 7, 2025
Highlights Total revenue of $1.54 billion, up 14% year over year Product revenue of $459 million, up 12% year over year Billings of $1.60 billion, up 14% year over year1 Unified SASE ARR2 up 26% and Security Operations ARR2 up 30%, year over year Record …
Matrix Service Company Reports Fiscal Year 2025 Third Quarter Results
GlobeNewswire
·
May 7, 2025
TULSA, Okla., May 07, 2025 (GLOBE NEWSWIRE) -- Matrix Service Company (Nasdaq: MTRX), a leading provider of engineering and construction services to the energy and industrial markets, today announced results for the third quarter of fiscal 2025 ended March …
Alto Ingredients, Inc. Reports First Quarter 2025 Results
GlobeNewswire
·
May 7, 2025
- Beverage-grade Liquid CO2 Processor Acquisition and Corporate Reorganization Deliver Improved Year-over-Year Gross Margin and Adjusted EBITDA - PEKIN, Ill., May 07, 2025 (GLOBE NEWSWIRE) -- Alto Ingredients, Inc. (NASDAQ: ALTO), a leading producer and …
MaxCyte Reports First Quarter 2025 Financial Results and Reiterates Full Year 2025 Guidance
GlobeNewswire
·
May 7, 2025
ROCKVILLE, MD, May 7, 2025 — MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics, …
LiveRamp to Discuss Fiscal 2025 Fourth Quarter and Full Year Results
GlobeNewswire
·
May 7, 2025
SAN FRANCISCO, May 07, 2025 (GLOBE NEWSWIRE) -- LiveRamp® (NYSE: RAMP), a leading data collaboration platform, today announced that its fiscal 2025 fourth quarter and full year earnings release will be issued on Wednesday, May 21, 2025 after the financial …
Generation Bio Reports Recent Business Highlights and First Quarter 2025 Financial Results
GlobeNewswire
·
May 7, 2025
- Company continues to advance its strategy to develop first-in-class treatments for T cell-driven autoimmune diseases using its cell-targeted lipid nanoparticle (ctLNP) technology to deliver siRNA - Lead target and portfolio strategy to be announced mid …
red violet Announces First Quarter 2025 Financial Results
GlobeNewswire
·
May 7, 2025
BOCA RATON, Fla., May 07, 2025 (GLOBE NEWSWIRE) -- Red Violet, Inc. (NASDAQ: RDVT), a leading analytics and information solutions provider, today announced financial results for the quarter ended March 31, 2025. “We are extremely pleased to report another …
Astera Labs to Participate in the J.P. Morgan 53rd Annual Global Technology, Media, and Communications Conference
GlobeNewswire
·
May 7, 2025
SANTA CLARA, Calif., May 07, 2025 (GLOBE NEWSWIRE) -- Astera Labs (Nasdaq: ALAB), a global leader in semiconductor-based connectivity solutions for AI and cloud infrastructure, today announced that it will participate in the J.P. Morgan 53rd Annual Global …
Crane NXT Reports First Quarter 2025 Results
GlobeNewswire
·
May 7, 2025
Completes Acquisition of De La Rue Authentication, a Global Leader in Security and Authentication Technologies Increases Sales Growth Guidance to 6% to 8% for Full Year 2025; Maintaining Full Year EPS Guidance of $4.00 to $4.30 WALTHAM, Mass., May 07, 2025 …
Akero Therapeutics to Present at the BofA Securities 2025 Healthcare Conference
GlobeNewswire
·
May 7, 2025
SOUTH SAN FRANCISCO, Calif., May 07, 2025 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational treatments for patients with serious metabolic diseases marked by high unmet medical need, today …
HeartCore to Present at Sidoti Micro-Cap Virtual Conference on May 21, 2025 at 11:30 a.m. ET
GlobeNewswire
·
May 7, 2025
NEW YORK and TOKYO, May 07, 2025 (GLOBE NEWSWIRE) -- HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or “the Company”), a leading enterprise software and data consulting services company based in Tokyo, will be virtually presenting and holding one- …
ADMA Biologics Announces First Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
May 7, 2025
1Q 2025 Total Revenue of $114.8 Million (Adjusted Total Revenue(1) of $118.6 Million), a 40% YoY Increase 1Q 2025 GAAP Net Income of $26.9 Million, a 51% YoY Increase 1Q 2025 Adjusted EBITDA(2) of $47.9 Million, an 81% YoY Increase 1Q 2025 Adjusted Net …
Aardvark Therapeutics to Present at Upcoming Investor Conferences in May
GlobeNewswire
·
May 7, 2025
SAN DIEGO, May 07, 2025 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (Aardvark) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment …
Cerence Announces Second Quarter Fiscal 2025 Results; Revenue and Profitability Exceed High End of Guidance
GlobeNewswire
·
May 7, 2025
Headlines Revenue of $78M; free cash flow of $13.1M marks fourth consecutive positive quarter Company reiterates full-year guidance for revenue and raises full-year guidance for profitability and cash flow Continued innovation and customer momentum for …